Detail

Study ID: COG ACNS1833

Title:

A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine versus Selumetinib (NSC# 748727, IND# 77782) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) not associated with BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1)

Location:
Fargo Region
Principal Investigator:
Samuel Milanovich, MD
Disease:
CNS (Brain Tumors)
Stage:
Phase III
Status:
Active - Open to Accrual